Biology Reference
In-Depth Information
(2008) Adenovirus serotype 5 hexon is critical
for virus infection of hepatocytes in vivo. Proc
Natl Acad Sci USA 105:5483-5488
13. Waddington SN, McVey JH, Bhella D, Parker
AL, Barker K, Atoda H et al (2008) Adenovirus
serotype 5 hexon mediates liver gene transfer.
Cell 132:397-409
14. Doronin K, Flatt JW, Di Paolo NC, Khare R,
Kalyuzhniy O, Acchione M et al (2012)
Coagulation factor X activates innate immu-
nity to human species C adenovirus. Science
338:795-798
15. Alba R, Bradshaw AC, Coughlan L, Denby L,
McDonald RA, Waddington SN et al (2010)
Biodistribution and retargeting of FX-binding
ablated adenovirus serotype 5 vectors. Blood
116:2656-2664
16. Alba R, Bradshaw AC, Parker AL, Bhella D,
Waddington SN, Nicklin SA et al (2009)
Identifi cation of coagulation factor (F)X bind-
ing sites on the adenovirus serotype 5 hexon:
effect of mutagenesis on FX interactions and
gene transfer. Blood 114:965-971
17. Xu Z, Qiu Q, Tian J, Smith JS, Conenello
GM, Morita T et al (2013) Coagulation factor
X shields adenovirus type 5 from attack by
natural antibodies and complement. Nat Med
19:452-457
18. Parker AL, Waddington SN, Buckley SM,
Custers J, Havenga MJ, van Rooijen N et al
(2009) Effect of neutralizing sera on factor
x-mediated adenovirus serotype 5 gene trans-
fer. J Virol 83:479-483
19. Abbink P, Lemckert AA, Ewald BA, Lynch
DM, Denholtz M, Smits S et al (2007)
Comparative seroprevalence and immunoge-
nicity of six rare serotype recombinant adeno-
virus vaccine vectors from subgroups B and D.
J Virol 81:4654-4663
20. Roberts DM, Nanda A, Havenga MJ, Abbink
P, Lynch DM, Ewald BA et al (2006) Hexon-
chimaeric adenovirus serotype 5 vectors cir-
cumvent pre-existing anti-vector immunity.
Nature 441:239-243
21. Cheng C, Gall JG, Nason M, King CR, Koup
RA, Roederer M et al (2010) Differential speci-
fi city and immunogenicity of adenovirus type 5
neutralizing antibodies elicited by natural infec-
tion or immunization. J Virol 84:630-638
22. Appledorn DM, McBride A, Seregin S, Scott
JM, Schuldt N, Kiang A et al (2008) Complex
interactions with several arms of the comple-
ment system dictate innate and humoral
immunity to adenoviral vectors. Gene Ther
15:1606-1617
23. Kiang A, Hartman ZC, Everett RS, Serra D,
Jiang H, Frank MM et al (2006) Multiple
innate infl ammatory responses induced after
systemic adenovirus vector delivery depend on
a functional complement system. Mol Ther
14:588-598
24. Adams WC, Bond E, Havenga MJ, Holterman
L, Goudsmit J, Karlsson Hedestam GB et al
(2009) Adenovirus serotype 5 infects human
dendritic cells via a coxsackievirus-adenovirus
receptor-independent receptor pathway medi-
ated by lactoferrin and DC-SIGN. J Gen Virol
90:1600-1610
25. Alba R, Baker AH, Nicklin SA (2012) Vector
systems for prenatal gene therapy: principles of
adenovirus design and production. Methods
Mol Biol 891:55-84
Search WWH ::




Custom Search